225 related articles for article (PubMed ID: 10427857)
1. [A new vaccine concept: polysaccharide conjugate vaccines].
Moreau M
Ann Pharm Fr; 1999 May; 57(3):223-31. PubMed ID: 10427857
[TBL] [Abstract][Full Text] [Related]
2. Conjugate vaccines--a breakthrough in vaccine development.
Mäkelä PH
Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):249-53. PubMed ID: 12971544
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM
J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066
[TBL] [Abstract][Full Text] [Related]
4. The promise of conjugate vaccines for Africa.
Kieny MP; LaForce FM
Vaccine; 2007 Sep; 25 Suppl 1():A108-10. PubMed ID: 17548136
[TBL] [Abstract][Full Text] [Related]
5. A conjugate vaccine composed of a heat shock protein 60 T-cell epitope peptide (p458) and Neisseria meningitidis type B capsular polysaccharide.
Amir-Kroll H; Riveron L; Sarmiento ME; Sierra G; Acosta A; Cohen IR
Vaccine; 2006 Oct; 24(42-43):6555-63. PubMed ID: 16843573
[TBL] [Abstract][Full Text] [Related]
6. Conjugate vaccines against group B Streptococcus types IV and VII.
Paoletti LC; Kasper DL
J Infect Dis; 2002 Jul; 186(1):123-6. PubMed ID: 12089673
[TBL] [Abstract][Full Text] [Related]
7. NMR assays for carbohydrate-based vaccines.
Jones C
J Pharm Biomed Anal; 2005 Aug; 38(5):840-50. PubMed ID: 16087046
[TBL] [Abstract][Full Text] [Related]
8. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
[TBL] [Abstract][Full Text] [Related]
9. Pneumococcal conjugate vaccines. A review.
Galiza EP; Heath PT
Minerva Med; 2007 Apr; 98(2):131-43. PubMed ID: 17519855
[TBL] [Abstract][Full Text] [Related]
10. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D
Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996
[TBL] [Abstract][Full Text] [Related]
11. A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b.
Verez-Bencomo V; Fernández-Santana V; Hardy E; Toledo ME; Rodríguez MC; Heynngnezz L; Rodriguez A; Baly A; Herrera L; Izquierdo M; Villar A; Valdés Y; Cosme K; Deler ML; Montane M; Garcia E; Ramos A; Aguilar A; Medina E; Toraño G; Sosa I; Hernandez I; Martínez R; Muzachio A; Carmenates A; Costa L; Cardoso F; Campa C; Diaz M; Roy R
Science; 2004 Jul; 305(5683):522-5. PubMed ID: 15273395
[TBL] [Abstract][Full Text] [Related]
12. Meningococcal vaccines.
Bethell D; Pollard AJ
Expert Rev Vaccines; 2002 Jun; 1(1):75-84. PubMed ID: 12908514
[TBL] [Abstract][Full Text] [Related]
13. Scientific challenges for the quality control and production of group C meningococcal conjugate vaccines.
Jódar L; Griffiths E; Feavers I
Vaccine; 2004 Feb; 22(8):1047-53. PubMed ID: 15161082
[TBL] [Abstract][Full Text] [Related]
14. Evolution of conjugate vaccines.
Mäkelä PH; Käyhty H
Expert Rev Vaccines; 2002 Oct; 1(3):399-410. PubMed ID: 12901578
[TBL] [Abstract][Full Text] [Related]
15. [Polysaccharide subunit vaccines].
Reinert P
Rev Prat; 1995 Jun; 45(12):1484-7. PubMed ID: 7660000
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ
Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736
[TBL] [Abstract][Full Text] [Related]
17. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
18. Thermostable formulations of a hepatitis B vaccine and a meningitis A polysaccharide conjugate vaccine produced by a spray drying method.
Chen D; Kapre S; Goel A; Suresh K; Beri S; Hickling J; Jensen J; Lal M; Preaud JM; Laforce M; Kristensen D
Vaccine; 2010 Jul; 28(31):5093-9. PubMed ID: 20478345
[TBL] [Abstract][Full Text] [Related]
19. [Conjugate vaccines].
Swennen B; Sternon J
J Pharm Belg; 2002; 57(4):73-81. PubMed ID: 12357695
[TBL] [Abstract][Full Text] [Related]
20. Immune response to pneumococcal conjugate and polysaccharide vaccines in otitis-prone and otitis-free children.
Barnett ED; Pelton SI; Cabral HJ; Eavey RD; Allen C; Cunningham MJ; McNamara ER; Klein JO
Clin Infect Dis; 1999 Jul; 29(1):191-2. PubMed ID: 10433584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
